Internal Medicine, Hematology & Oncology · Atlanta, GA
NPI
1174787352
Since 2008
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
49 Jesse Hill Jr Dr SE
Atlanta, GA, 30303
Phone (404) 778-1480
Groups this clinician bills Medicare through
Medicare paid, 2024
$14K
189 services
Medicare patients, 2024
87
Average age 55
Drug cost, 2024
$524K
2,007 prescriptions
Company payments, 2025
$24K
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Fuad El Rassi was code 99233 (hospital e&m - subsequent), 42 times for 23 patients. In total Fuad El Rassi billed 189 services in 15 codes, and Medicare paid $14K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-08-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 42 | 23 | $93.51 | $3,927 |
| 99232 Hospital E&M - Subsequent | Facility | 35 | 17 | $61.98 | $2,169 |
| 99214 Office E&M - Established | Facility | 26 | 19 | $69.80 | $1,815 |
| 99215 Office E&M - Established | Facility | 19 | 12 | $113.65 | $2,159 |
| 99222 Hospital E&M - Initial | Facility | 19 | 18 | $103.06 | $1,958 |
By year: 2022 $9,662 for 156 services; 2023 $9,720 for 154 services; 2024 $14K for 189 services.
Medicare prescription drug claims, 2024
In 2024, the drug Fuad El Rassi prescribed most often to Medicare patients was Hydroxyurea, with 286 prescriptions and refills. In total Fuad El Rassi wrote 2,007 Medicare prescriptions that cost $524K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxyurea Generic | 286 | 400 | 85 | $7,337 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 281 | 281 | 65 | $5,087 |
| Oxycodone Hcl Generic | 247 | 247 | 62 | $3,437 |
| Morphine Sulfate Er Morphine Sulfate | 198 | 198 | 46 | $6,048 |
| Ibuprofen Generic | 102 | 102 | 35 | $415 |
| Promethazine Hcl Generic | 67 | 67 | 11 | $268 |
| Oxycontin Oxycodone Hcl | 66 | 66 | 16 | $49K |
| Losartan Potassium Generic | 47 | 88 | 20 | $168 |
| Eliquis Apixaban | 45 | 54 | 13 | $31K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 41 | 41 | 11 | $830 |
| Gabapentin Generic | 36 | 43 | 11 | $337 |
| Morphine Sulfate Generic | 34 | 34 | Under 11 | $866 |
| Methadone Hcl Generic | 30 | 30 | Under 11 | $589 |
| Xarelto Rivaroxaban | 26 | 42 | Under 11 | $22K |
| Deferasirox Generic | 26 | 26 | Under 11 | $66K |
Brand drugs: - claims; generic drugs: 1,771 claims; opioid claims: 930.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Fuad El Rassi $24K ($24K in general payments such as food, travel and fees) from 7 companies. The largest payer was Agios Pharmaceuticals, Inc. with $9,565.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.